| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/12/2008 | US20080138336 Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | CA2699837A1 Variant target binding agents and uses thereof |
| 06/12/2008 | CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 06/12/2008 | CA2664219A1 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 06/11/2008 | EP1930415A1 Development of method for screening of compound capable of improving the production of regulatory t cell, and method for production of regulatory t cell using immunosuppressive macrolide antibiotic |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930025A1 ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930001A1 Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 06/11/2008 | EP1928877A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 06/11/2008 | EP1928876A1 Purine derivatives having immuno-modulating properties |
| 06/11/2008 | EP1928845A2 Aminodiazepines as toll-like receptor modulators |
| 06/11/2008 | EP1928821A1 Carboxamide derivatives as muscarinic receptor antagonists |
| 06/11/2008 | EP1928492A2 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/11/2008 | EP1301637B1 Dna vaccines encoding hiv accessory proteins |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198353A Immunomodulating compositions and uses therefor |
| 06/11/2008 | CN101195799A SOD distillate spirits and manufacturing method thereof |
| 06/11/2008 | CN101195649A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 06/11/2008 | CN101195559A Process for producing resveratrol nano-crystallization and uses thereof |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195009A Powder medicament for treating scrotum eczema |
| 06/11/2008 | CN101194996A Chinese medicine ejection preparation and method for preparing the same |
| 06/11/2008 | CN101194968A Traditional Chinese medicine preparation for treating urticaria |
| 06/11/2008 | CN101194955A Fumigation medicament for treating eczema |
| 06/11/2008 | CN101194952A Plaster medicament for treating eczema |
| 06/11/2008 | CN101194923A Novel medicament for treating systematic lupus erythematosus |
| 06/11/2008 | CN101194919A Hippophae rhamnoides seed oil fatty milk injection and technique of preparing the same |
| 06/11/2008 | CN101194906A Dropping pills for treating hypersensitivity disease and method for preparing the same |
| 06/11/2008 | CN101194902A Dropping pills containing ubenimex and method for preparing the same |
| 06/11/2008 | CN101194892A Dropping pills containing benproperine phosphate and method for preparing the same |
| 06/11/2008 | CN101194889A Cyclosporin A nano-grain self-emulsifying freeze drying powder preparations and method for preparing the same |
| 06/11/2008 | CN100393722C Inhibitors of nucleoside metabolism |
| 06/11/2008 | CN100393327C Chewing tablet of Taishan radix cynanchi bungei, its preparing method and use |
| 06/11/2008 | CN100393313C Bilobalide B powder injection and its preparing method |
| 06/11/2008 | CN100393312C Soft capsule of mycophenolic acid or like and its preparing method |
| 06/11/2008 | CN100393230C Feedstuff addictive and its preparing technology and application in process for manufacturing birds flu-preventing feedstuff |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384951 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384635 Protein variants of naturally occurring allergens |
| 06/10/2008 | US7384633 Human type antihuman IgE receptor antibody and fragment |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2319010C Pharmaceutical compositions |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008064830A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses |
| 06/05/2008 | WO2008064552A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 06/05/2008 | WO2008035206A3 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 06/05/2008 | WO2008031092A3 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 06/05/2008 | WO2008017473A3 Structure and use of 5' phosphate oligonucleotides |
| 06/05/2008 | WO2008012645A3 Use of vitamin d3 agonist in a mammalian model for atopic diseases and of vitamin d3 antagonists for the treatment of atopic diseases |
| 06/05/2008 | WO2007074349A3 Mineral-herbal preparation consisting of zeolite and astragalus membranaceus root extract to treat allergies |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132536 treatment or prophylaxis of inflammatory or allergic diseases chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, allergic rhinitis or atopic dermatitis; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[1-(2,4-dimethylphenyl)propyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide |
| 06/05/2008 | US20080132534 Pharmaceutical composition comprising a macrolide immunomodulator |
| 06/05/2008 | US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant |
| 06/05/2008 | US20080132505 Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine |
| 06/05/2008 | US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders |
| 06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
| 06/05/2008 | US20080132463 Pharmaceutical use of alpha antigen or alpha antigen gene |
| 06/05/2008 | US20080132452 treating a an autoimmune condition; administering polypeptide; Goodpasture Syndrome, multiple sclerosis, systemic lupus erythematosus, cutaneous lupus erythematosus, pemphigus, pemphigoid and lichen planus |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131466 Glucopyranosyl lipid adjuvant; toll-like receptors; saponins; kits |
| 06/05/2008 | US20080131465 Group a Streptococcus Crge Protein |
| 06/05/2008 | US20080131455 Antigen Delivery Compositions And Methods Of Use |
| 06/05/2008 | US20080131443 Method and composition for reconforming multi-epitopic antigens to intiate an immune response |
| 06/05/2008 | US20080131440 Using ultra-low doses of monoconal, polycloncal or natural antibodies to treat infectious disease |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131433 Fc Receptor Homolog Antibodies And Uses Thereof |
| 06/05/2008 | US20080131418 Using concentration of beta crystallin as diagnostic indicator of eye disorders |
| 06/05/2008 | US20080131416 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 06/05/2008 | US20080131413 Method for preventing or treating the development of respiratory allergies |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131371 Oligonucleotide Non-Viral Delivery Systems |